Copyright Reports & Markets. All rights reserved.

Global Topotecan Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Topotecan Market Overview

    • 1.1 Product Overview and Scope of Topotecan
    • 1.2 Classification of Topotecan by Types
      • 1.2.1 Global Topotecan Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Topotecan Revenue Market Share by Types in 2018
      • 1.2.3 Capsules
      • 1.2.4 Injection
    • 1.3 Global Topotecan Market by Application
      • 1.3.1 Global Topotecan Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Ovarian Cancer
      • 1.3.3 Lung Cancer
      • 1.3.4 Other Cancer types
    • 1.4 Global Topotecan Market by Regions
      • 1.4.1 Global Topotecan Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Topotecan Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Topotecan Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Topotecan Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Topotecan Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Topotecan Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Topotecan (2014-2024)

    2 Manufacturers Profiles

    • 2.1 GSK
      • 2.1.1 Business Overview
      • 2.1.2 Topotecan Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GSK Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Teva
      • 2.2.1 Business Overview
      • 2.2.2 Topotecan Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Teva Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Fresenius Kabi
      • 2.3.1 Business Overview
      • 2.3.2 Topotecan Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Cipla
      • 2.4.1 Business Overview
      • 2.4.2 Topotecan Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Cipla Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Sagent Pharmaceuticals
      • 2.5.1 Business Overview
      • 2.5.2 Topotecan Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Mylan
      • 2.6.1 Business Overview
      • 2.6.2 Topotecan Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Mylan Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Topotecan Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Topotecan Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Dr. Reddy's Laboratories
      • 2.8.1 Business Overview
      • 2.8.2 Topotecan Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Dr. Reddy's Laboratories Topotecan Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Topotecan Market Competition, by Players

    • 3.1 Global Topotecan Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Topotecan Players Market Share
      • 3.2.2 Top 10 Topotecan Players Market Share
    • 3.3 Market Competition Trend

    4 Global Topotecan Market Size by Regions

    • 4.1 Global Topotecan Revenue and Market Share by Regions
    • 4.2 North America Topotecan Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Topotecan Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Topotecan Revenue and Growth Rate (2014-2019)
    • 4.5 South America Topotecan Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Topotecan Revenue and Growth Rate (2014-2019)

    5 North America Topotecan Revenue by Countries

    • 5.1 North America Topotecan Revenue by Countries (2014-2019)
    • 5.2 USA Topotecan Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Topotecan Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Topotecan Revenue and Growth Rate (2014-2019)

    6 Europe Topotecan Revenue by Countries

    • 6.1 Europe Topotecan Revenue by Countries (2014-2019)
    • 6.2 Germany Topotecan Revenue and Growth Rate (2014-2019)
    • 6.3 UK Topotecan Revenue and Growth Rate (2014-2019)
    • 6.4 France Topotecan Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Topotecan Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Topotecan Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Topotecan Revenue by Countries

    • 7.1 Asia-Pacific Topotecan Revenue by Countries (2014-2019)
    • 7.2 China Topotecan Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Topotecan Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Topotecan Revenue and Growth Rate (2014-2019)
    • 7.5 India Topotecan Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Topotecan Revenue and Growth Rate (2014-2019)

    8 South America Topotecan Revenue by Countries

    • 8.1 South America Topotecan Revenue by Countries (2014-2019)
    • 8.2 Brazil Topotecan Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Topotecan Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Topotecan Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Topotecan by Countries

    • 9.1 Middle East and Africa Topotecan Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Topotecan Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Topotecan Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Topotecan Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Topotecan Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Topotecan Revenue and Growth Rate (2014-2019)

    10 Global Topotecan Market Segment by Type

    • 10.1 Global Topotecan Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Topotecan Market Forecast by Type (2019-2024)
    • 10.3 Capsules Revenue Growth Rate (2014-2024)
    • 10.4 Injection Revenue Growth Rate (2014-2024)

    11 Global Topotecan Market Segment by Application

    • 11.1 Global Topotecan Revenue Market Share by Application (2014-2019)
    • 11.2 Topotecan Market Forecast by Application (2019-2024)
    • 11.3 Ovarian Cancer Revenue Growth (2014-2019)
    • 11.4 Lung Cancer Revenue Growth (2014-2019)
    • 11.5 Other Cancer types Revenue Growth (2014-2019)

    12 Global Topotecan Market Size Forecast (2019-2024)

    • 12.1 Global Topotecan Market Size Forecast (2019-2024)
    • 12.2 Global Topotecan Market Forecast by Regions (2019-2024)
    • 12.3 North America Topotecan Revenue Market Forecast (2019-2024)
    • 12.4 Europe Topotecan Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Topotecan Revenue Market Forecast (2019-2024)
    • 12.6 South America Topotecan Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Topotecan Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

      Scope of the Report:
      The global Topotecan market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Topotecan.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Topotecan market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Topotecan market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      GSK
      Teva
      Fresenius Kabi
      Cipla
      Sagent Pharmaceuticals
      Mylan
      Pfizer
      Dr. Reddy's Laboratories

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Capsules
      Injection

      Market Segment by Applications, can be divided into
      Ovarian Cancer
      Lung Cancer
      Other Cancer types

      Buy now